Clinical Study

Effluent Markers Related to Epithelial Mesenchymal Transition with Adjusted Values for Effluent Cancer Antigen 125 in Peritoneal Dialysis Patients

Table 2

Effluent markers and effluent markers-to-effluent cancer antigen 125 ratio in patients with high transport rate and others.

GroupPatients with high transport rateOthers

1491
Effluent HGF (pg/mL)240.0 (197.5–319.3)***133.0 (107.0–216.0)
Effluent HGF/CA125 (pg/U)19.0 (10.8–33.2)13.7 (8.0–25.9)
Effluent BMP-7 (pg/mL)8.3 (7.4–9.4)7.5 (4.8–9.1)
Effluent BMP-7/CA125 (pg/U)0.6 (0.5–0.8)0.6 (0.3–1.2)
Effluent VEGF (pg/mL)33.0 (29.0–34.0)**25.0 (20.0–31.0)
Effluent VEGF/CA125 (pg/U)2.5 (1.7–3.7)2.3 (1.4–3.7)
Effluent IL-6 (pg/mL)23.8 (13.9–35.1)*11.6 (6.7–24.0)
Effluent IL-6/CA125 (pg/U)1.9 (1.3–2.2)*1.1 (0.6–1.8)
Effluent CA125 (U/mL)13.3 (7.6–18.9)11.1 (6.3–20.0)

Data are medians with 25 and 75% interquartile ranges in parentheses.
HGF: hepatocyte growth factor, BMP-7: bone morphogenic protein-7, VEGF: vascular endothelial growth factor, IL-6: interleukin-6, CA125: cancer antigen 125.
* compared with others, ** compared with others, *** compared with others.